Why Medtronic And Abbott Stocks Are Sinking
Portfolio Pulse from Ryan Gustafson
Shares of Medtronic plc. (NYSE:MDT) and Abbott Laboratories (NYSE:ABT) are trading lower after the U.S. Food and Drug Administration (FDA) established a Digital Health Advisory Committee. The committee will explore issues related to digital health technologies and will be fully operational in 2024. At the time of publication, shares of MDT were down 4.86% at $72.48 while shares of ABT were down 5.13% at $92.55.
October 11, 2023 | 7:08 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Shares of Abbott Laboratories are trading lower after the FDA established a Digital Health Advisory Committee.
The establishment of the FDA's Digital Health Advisory Committee may lead to stricter regulations for digital health technologies, potentially impacting Abbott Laboratories' operations and profitability.
CONFIDENCE 90
IMPORTANCE 75
RELEVANCE 100
NEGATIVE IMPACT
Shares of Medtronic plc. are trading lower after the FDA established a Digital Health Advisory Committee.
The establishment of the FDA's Digital Health Advisory Committee may lead to stricter regulations for digital health technologies, potentially impacting Medtronic's operations and profitability.
CONFIDENCE 90
IMPORTANCE 75
RELEVANCE 100